Next 10 |
home / stock / blco / blco articles
Oppenheimer initiated coverage on Clearside Biomedical Inc (NASDAQ:CLSD), a biopharmaceutical company focused on delivering therapies to the back o...
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
A negative sentiment might linger on Wall Street on Wednesday, as evidenced by stock futures, after Advanced Micro Devices, Inc.‘s (NASD...
Shares of International Flavors & Fragrances Inc. (NYSE: IFF) fell during Wednesday’s session after the company reported mixed fourth-qu...
U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Wednesday. Shares of Toll Brothers, Inc. (NYSE: TOL) gained duri...
Papa will lead Emergent into a new era of focusing on protecting public health, returning to growth and paying down the company's debt GAIT...
Wall Street remains subdued following Tuesday’s sell-off, primarily driven by small-cap and tech stocks. All eyes are now on Nvidia Corp...
Eye health products company Bausch + Lomb Corp (NYSE:BLCO) is scheduled to release its fourth-quarter and full-year 2023 financial result...
Stocks experienced a modest surge amid the Federal Open Market Committee meeting Wednesday. The central bank is widely expected to leave interest r...
News, Short Squeeze, Breakout and More Instantly...
Bausch + Lomb Corporation Company Name:
BLCO Stock Symbol:
NYSE Market:
Bausch + Lomb Corporation Website:
Dayforce Inc. (DAY) is expected to report $0.18 for Q2 2024 D/B/A Compass Diversified Holdings Shares of Beneficial Interest (CODI) is expected to report $0.44 for Q2 2024 Aurora Innovation Inc. (AUR) is expected to report for Q2 2024 Autohome Inc. American Depositary Shares each repr...
Revenue of $1.216 Billion GAAP Net Loss Attributable to Bausch + Lomb Corporation of $151 Million Adjusted EBITDA (non-GAAP ) 1 of $209 Million Revenue Grew 17% as Reported and 20% on a Constant Currency 1 Basis Compared to the Second Quarter of 2023, Driven by...
Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its second-quarter 2024 financial results on Wednesday, July 31, 2024. Bausch + Lomb will host a conference call and live webcast at 8 a.m. ET to dis...